Cannara Biotech finalise l’acquisition de Medican Organic ; Nicholas Sosiak nommé au poste de COO

Cannara Biotech a clôturé mercredi l’acquisition de Medican Organic, une unité de BZAM Ltd., pour un montant de 2,8 millions de dollars. Cette opération vient parachever …

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
528